<code id='E1BCB7A07E'></code><style id='E1BCB7A07E'></style>
    • <acronym id='E1BCB7A07E'></acronym>
      <center id='E1BCB7A07E'><center id='E1BCB7A07E'><tfoot id='E1BCB7A07E'></tfoot></center><abbr id='E1BCB7A07E'><dir id='E1BCB7A07E'><tfoot id='E1BCB7A07E'></tfoot><noframes id='E1BCB7A07E'>

    • <optgroup id='E1BCB7A07E'><strike id='E1BCB7A07E'><sup id='E1BCB7A07E'></sup></strike><code id='E1BCB7A07E'></code></optgroup>
        1. <b id='E1BCB7A07E'><label id='E1BCB7A07E'><select id='E1BCB7A07E'><dt id='E1BCB7A07E'><span id='E1BCB7A07E'></span></dt></select></label></b><u id='E1BCB7A07E'></u>
          <i id='E1BCB7A07E'><strike id='E1BCB7A07E'><tt id='E1BCB7A07E'><pre id='E1BCB7A07E'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:46
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes
          Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

          EricRisberg/APTwodominantBlueCrossBlueShieldcompaniesinCaliforniaintentionallyunderreportedpremiumso

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Medicare has a new plan to address drug shortages

          Medicarehasanewproposaltopayhospitalsmoretostockpileessentialdrugs,anefforttoavoidshortagesofchemoth